Terkko Navigator / JAMA Internal Medicine

JAMA Internal Medicine

Errors in Group Information Supplement and End Matter

Diversity and Representation of Physicians During the COVID-19 News Cycle

Error in Author Order of the Byline

Corrections to Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions

Coding Errors Resulting in Some US State Misclassifications

The Assessment of Different Diets and Mortality Fails to Address Unmeasured Confounding—Reply

The Assessment of Different Diets and Mortality Fails to Address Unmeasured Confounding

Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers

Addressing Spiritual and Religious Needs in Advanced Illness

No Bad Blood—Surviving Severe Anemia Without Transfusion

Nutritional Analysis of Foods and Beverages Depicted in Top-Grossing US Movies, 1994-2018

Disparities in Secondhand Smoke Exposure in the United States

Association of Neighborhood Characteristics and Travel Patterns With Fatal Drug Overdoses

Association of Therapies With Pain and Quality of Life in Patients With Fibromyalgia

Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion for Symptomatic Hyponatremia

Prediction Models for COVID-19 Need Further Improvements

Risk of Severe COVID-19 Among Workers and Their Household Members

Implications of Changes in Health Care Spending Early in the COVID-19 Pandemic

Misuse and Neologisms in Clinical Communication

Syncope Due to Complete Heart Block

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Effect of Tocilizumab on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia

Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life

Complexities and Outcomes of Advance Care Planning

Anticoagulation Therapy and Fall Reduction

Noninvasive Ventilation in Seriously Ill Older Adults at the End of Life—The Evidence Remains Elusive

Assessment of the US Food and Drug Administration Review of Biosimilar Biologic Products

Inaccurate Estimates of Negotiated Reimbursement Prices for Insulin—Reply

Inaccurate Estimates of Negotiated Reimbursement Prices for Insulin

Severe COVID-19 Infections—Knowledge Gained and Remaining Questions

Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With COVID-19 and Lymphopenia

Immune Stimulation With Recombinant Human Granulocyte Colony–Stimulating Factor for Coronavirus Disease 2019 (COVID-19)

Assessing Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions

Addressing the Cost of Biologic and Specialty Drugs

Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States

The Uncertain Role of Corticosteroids in the Treatment of COVID-19—Reply

The Uncertain Role of Corticosteroids in the Treatment of COVID-19

The Uncertain Role of Corticosteroids in the Treatment of COVID-19

Universal COVID-19 Testing Following Detection of Incident Cases in 11 Long-term Care Facilities

JAMA Internal Medicine

Implantable Cardioverter Defibrillator Management at the End of Life

Medicine and Grief During the COVID-19 Era

Stopping Superfluous Shocks With System Solutions

Scorpion Sting With ST-Segment Elevation

Association of Medicaid Managed Care Plan Type With Outpatient and Acute Care

Asymptomatic and Presymptomatic SARS-CoV-2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities

Error in Funding/Support Section of End Matter